Abingworth
Venture Capital and Private Equity PrincipalsEngland, United Kingdom11-50 Employees
Abingworth operates as a transatlantic life sciences investment firm that supports turning advanced scientific discoveries into new medicines by providing both capital and strategic guidance to management teams building biotechnology companies. Its therapeutic investments span three stages—seed and early development, development, and clinical co-development—reflecting a broad approach to advancing programs through development. The aim is to help portfolio companies progress with access to experienced professionals and a cross-border network. Headquartered in London, England, with offices in Menlo Park, California, and Boston, the firm maintains a cross-border footprint across Europe and North America. Founded in 1973, Abingworth has backed more than 180 life science companies, resulting in 46 mergers and acquisitions and more than 70 IPOs. In August 2022, it became part of Carlyle.
1-888-653-2347 
support@leadiq.com 
